VWM
MDT icon

Vermillion Wealth Management’s Medtronic MDT Stock Holding History

Vermillion Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Sell
3,314
-169
-5% -$13.6K 0.06% 142
2026
Q1 		$302K Buy
3,483
+72
+2% +$6.9K 0.12% 76
2025
Q4 		$328K Hold
3,411
– – 0.13% 69
2025
Q3 		$325K Hold
3,411
– – 0.09% 109
2025
Q2 		$297K Sell
3,411
-603
-15% -$51.1K 0.14% 64
2025
Q1 		$361K Sell
4,014
-39
-1% -$3.49K 0.11% 99
2024
Q4 		$324K Buy
+4,053
New +$351K 0.17% 63

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vermillion Wealth Management's MDT Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Medtronic (MDT) stake by 4.9% in Q2 2026, selling an estimated $13.6K and leaving 3,314 shares worth $259K. The position accounts for 0.06% of the portfolio, ranked #142.

Vermillion Wealth Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $361K in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vermillion Wealth Management held 3,314 shares of Medtronic worth $259K as of Q2 2026.
  • Vermillion Wealth Management sold 169 Medtronic shares in Q2 2026, an estimated $13.6K.
  • Medtronic made up 0.06% of Vermillion Wealth Management's portfolio in Q2 2026, its #142 holding.
  • Vermillion Wealth Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Medtronic position peaked at $361K in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.